Amplec Healthcare Pvt. Ltd. has established itself as a trusted PD Based Pharma Company Franchise in India by delivering premium-quality pharmaceutical formulations and profitable franchise opportunities. The company primarily focuses on the cardiac and diabetic segment, offering scientifically developed medicines manufactured in WHO-GMP certified facilities while complying with DCGI, GMP, ISO 9001, and GLP quality standards. With an extensive portfolio of 300+ pharmaceutical formulations, Amplec Healthcare serves healthcare professionals, distributors, and entrepreneurs across the country.
The company provides complete franchise solutions, including monopoly rights, promotional materials, visual aids, product catalogues, marketing assistance, and dedicated business support. In addition to its specialized cardiac and diabetic range, Amplec Healthcare also offers tablets, capsules, syrups, injectables, softgel capsules, ointments, protein supplements, pediatric formulations, dermatology products, and Ayurvedic medicines, enabling franchise partners to build a diversified pharmaceutical business.
Supported by a strong research-driven approach, modern manufacturing standards, and a customer-centric philosophy, Amplec Healthcare continuously invests in innovation and quality improvement. The company's transparent business practices, affordable investment model, reliable supply chain, and long-term franchise support have positioned it among the preferred PD Based Pharma Company Franchise providers in India.
Amplec Healthcare follows stringent WHO-GMP, DCGI, ISO, and GLP quality standards, ensuring every pharmaceutical formulation undergoes rigorous testing for safety, purity, efficacy, and regulatory compliance.
To deliver affordable, quality-assured pharmaceutical products while empowering franchise partners through ethical practices, scientific innovation, and reliable healthcare solutions across India.
To become India's most trusted pharmaceutical franchise company by driving innovation, maintaining world-class quality standards, and building sustainable partnerships that improve global healthcare.
N/A